PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2014 | 89 | 07 |
Tytuł artykułu

Chłoniaki u kotów - przegląd aktualnego piśmiennictwa

Treść / Zawartość
Warianty tytułu
EN
Lymphomas in cats - review of current literature
Języki publikacji
PL
Abstrakty
EN
Wydawca
-
Rocznik
Tom
89
Numer
07
Opis fizyczny
s.563-572,fot.,bibliogr.
Twórcy
  • Zakład Patomorfologii Zwierząt, Katedra Patologii i Diagnostyki Weterynaryjnej, Wydział Medycyny Weterynaryjnej,Szkoła Główna Gospodarstwa Wiejskiego, Warszawa
  • Zakład Patomorfologii Zwierząt, Katedra Patologii i Diagnostyki Weterynaryjnej, Wydział Medycyny Weterynaryjnej,Szkoła Główna Gospodarstwa Wiejskiego, Warszawa
Bibliografia
  • 1. Jacobs R., Messic J., Valli V.: Tumors of the hemolymphatic system. W: Tumors in Domestic Animals, 4th ed., 2002.
  • 2. Vail D: Feline lymphoma and leukemia. W: Small Animal Clinical Oncology, 4th ed., 2007.
  • 3. Schmidt J., North S., Freeman K., Ramiro-Ibanez F.: Feline paediatric oncology: retrospective assessment of 233 tumoursfrom cats up to one year (1993 to 2008). J. SmallAnim. Pract. 2010, 51, 306–11.
  • 4. Valli V., Jacobs R., Norris A.: The histologic classification of 602 cases of feline lymphoproliferative disease usingthe National Cancer Institute Working Formulation. J.Vet. Diagn. Invest. 2000, 12, 295–306.
  • 5. Sweetenham J., Smartt P., Wilkins B.: The clinical utility of the Revised European-American Lymphoma (R.E.A-.L.) Classification: preliminary results of a prospectivestudy in patients with non–Hodgkin’s lymphoma froma single centre. Ann. Oncol. 1999, 10, 1121–1124.
  • 6. Lennert K.: Malignant Lymphomas Other Than Hodgkin’s Disease. Springer-Verlag. 1978.
  • 7. National Cancer Institute sponsored study of classification of non–Hodgkin’s lymphomas: 1982, Summary anddescription of a Working Formulation for clinical usage.The Non–Hodgkin’s Lymphoma Pathologic ClassificationProject. Cancer. 1982, 49, 2112–2135.
  • 8. Chino J., Fujino Y., Kobayashi T., Kariya K., Goto-Koshino Y., Ohno K., Nakayama H., Tsujimoto H.: Cytomorphological and immunological classification of feline lymphomas: clinicopathological features of 76 cases. J. Vet.Med. Sci. 2013, 75, 701–7.
  • 9. Meichner K., Kruse B., Hirschberger J., Hartmann K.: Changes in prevalence of progressive feline leukaemiavirus infection in cats with lymphoma in Germany. Vet.Rec. 2012, 171, 348.
  • 10. Barrs V., Beatty J.: Feline alimentary lymphoma: 1. Classification, risk factors, clinical signs and non-invasive diagnostics.J. Feline Med. Surg. 2012, 14, 182.
  • 11. Simon D., Eberle N., Laacke-Singer L., Nolte I.: Combination chemotherapy in feline lymphoma: treatment outcome,tolerability and duration in 23 cats. J. Vet. Intern.Med. 2008, 22, 394–400.
  • 12. Rissetto K., Villamil J., Selting K., Tyler J., Henry C.: Recent trends in feline intestinal neoplasia: an epidemiologicstudy of 1129 cases in the Veterinary Medical Databasefrom 1964 to 2004. J. Am. Anim. Hosp. Assoc. 2011,47, 28–36.
  • 13. Pohlman L., Higginbotham M., Welles E., Johnson C.: Immunophenotypic and histologic classification of 50 cases of feline gastrointestinal lymphoma. Vet. Pathol. 2009, 46,259–268.
  • 14. Moore P.: Feline gastrointestinal lymphoma: mucosal architecture, immunophenotype and molecular clonality. Concurrent Meetings of the ACVP and the ASVCP. 2006, 108–112.
  • 15. Bridgeford E., Marini R., Feng Y., Parry N., Rickman B., Fox J:. Gastric Helicobacter species as a cause of feline gastric lymphoma: a viable hypothesis. Vet. Immunol. Immunopathol. 2008, 123, 106–113.
  • 16. Kiupel M., Smedley R., Pfent C., Xie Y., Xue Y., Wise A.: Diagnostic algorithm to differentiate lymphoma from inflammation in feline intestinal biopsy specimens. Vet. Pathol. 2011, 48, 212–222.
  • 17. Zwingenberger A., Marks S., Baker T., Moore P.: Ultrasonographic evaluation of the muscularis propria in cats with diffuse small intestinal lymphoma or inflammatory bowel disease. J. Vet. Intern. Med. 2010, 24, 289–292.
  • 18. Lingard A., Briscoe K., Beatty J., Moore A., Crowley A.,Krockenberger M.: Low-grade alimentary lymphoma: clinicopathological findings and response to treatment in 17 cases. J. Feline Med. Surg. 2009, 11, 692–700.
  • 19. Russell K., Beatty J., Dhand N., Gunew M., Lingard A., Baral R.: Feline low-grade alimentary lymphoma (LGAL) – how common is it? Proc. ACVS. 2011
  • 20. Kleinschmidt S., Harder J., Nolte I., Marsilio S., Hewicker– Trautwein M.: Chronic inflammatory and noninflammatorydiseases of the gastrointestinal tract in cats: diagnostic advantages of full-thickness intestinal and extraintestinal biopsies. J. Feline Med. Surg. 2010, 12, 97–103.
  • 21. Briscoe K., Krockenberger M., Beatty J., Crowley A., Dennis M., Canfield P., Dhandx N., Lingard A., Barrs V.: Lymphoplasmacytic enteritis and low-grade alimentary lymphoma.J. Comp. Pathol. 2011, 145, 187–198.
  • 22. Scott K., Zoran D., Mansell J., Norby B., Willard M.: Utility of endoscopic biopsies of the duodenum and ileum for diagnosis of inflammatory bowel disease and small cell lymphomain cats. J. Vet. Intern. Med. 2011, 25, 1253–1257.
  • 23. Takeuchi Y., Takahashi M., Tsuboi M., Fujino Y, Uchida K, Ohno K, Nakayama H., Tsujimoto H. Intestinal T-cell lymphoma with severe hypereosinophilic syndrome in a cat. J. Vet. Med. Sci. 2012, 74, 1057–1062.
  • 24. Cesari A., Bettini.G, Vezzali E.: Feline Intestinal T-Cell Lymphoma: Assessment of morphologic and kinetic features in 30 Cases. J. Vet. Diagn. Invest. 2009, 21, 277.
  • 25. Daniaux L., Laurenson M., Marks S., Moore P., Taylor S., Chen R., Zwingenberger A.: Ultrasonographic thickening of the muscularis propria in feline small intestinal small cell T-cell lymphoma and inflammatory bowel disease. J. Feline Med. Surg. 2014, 16, 89–98.
  • 26. Wilson S., Thomson-Kerr K., Houston D.: Hypereosinophilic syndrome in a cat. Can. Vet. J. 1996, 37, 679–680.
  • 27. Gleich G., Leiferman K.: The hypereosinophilic syndromes: current concepts and treatments. Br. J. Haem. 2009,145, 271–285.
  • 28. Burke K., Broussard J., Ruaux C., Suchodolski J., Williams D., Steiner J.: Evaluation of fecal α1-proteinase inhibitorconcentrations in cats with idiopathic inflammatory boweldisease and cats with gastrointestinal neoplasia. Vet.J. 2013, 196, 189–196.
  • 29. Taylor S., Dodkin S, Papasouliotis K, Evans H, Graham P., Belshaw Z, Westberg S, von Euler H.: Serum thymidine kinase activity in clinically healthy and diseased cats: a potential biomarker for lymphoma. J. Feline Med. Surg. 2013, 15, 142–147.
  • 30. Swanson C., Smedley R., Saavedra P., Kiupel M., Kitchell B.: Expression of the Bcl-2 apoptotic marker in cats diagnosedwith inflammatory bowel disease and gastrointestinallymphoma. J. Feline Med. Surg. 2012, 14, 741–745.
  • 31. Taylor S., Goodfellow M., Browne W., Walding B., Murphy S., Tzannes S., Gerou-Ferianni M., Schwartz A., Dobson J.: Feline extranodal lymphoma: response to chemotherapyand survival in 110 cats. J. Small Anim. Pract. 2009,50, 584–592.
  • 32. Bennett S., Holland, J., Meehan M.: Mural lymphoma associated with the urinary bladder of a cat. Austr Vet Pract. 2003, 33, 155–159.
  • 33. Benigni L., Lamb C., Corzo-Menendez N., Holloway A., Eastwood J.: Lymphoma affecting the urinary bladder in three dogs and a cat. Vet. Radiol. Ultrasound. 2006, 47,592–596.
  • 34. Amati M., Venco L., Roccabianca P., Santagostino S., Bertazzolo W.: Pericardial lymphoma in seven cats. J. FelineMed. Surg. 2013, Oct 9. [Epub ahead of print]
  • 35. Little L., Patel R., Goldschmidt M.: Nasal and nasopharyngeal lymphoma in cats: 50 cases (1989–2005). Vet. Pathol.2007, 44, 885–892.
  • 36. Nagata K., Lamb M., Goldschmidt M., Duda L., Walton R.: The usefulness of immunohistochemistry to differentiatebetween nasal carcinoma and lymphoma in cats: 140 cases (1986–2000). Vet. Comp. Oncol. 2014, 12, 52–57.
  • 37. Marioni-Henry K., Vite C., Newton A., VanWinkle T.: Prevalence of diseases of the spinal cord of cats. J. Vet.Intern. Med. 2004, 18, 851–858.
  • 38. Zaki F., Hurvitz A.: Spontaneous neoplasms of the central nervous system of the cat. J. Small Anim. Pract. 1976,17, 773–82.
  • 39. Morita T., Kondo H., Okamoto M., Park C., Sawashima Y., Shimada A.: Periventricular spread of primary centralnervous system T-cell lymphoma in a cat. J. Comp. Pathol.2009, 140, 54–58.
  • 40. Giordano C., Giudice C., Bellino C., Borrelli A., D’Angelo A., Gianella P.: A case of oculo-cerebral B-cell lymphomain a cat. Vet. Ophthalm. 2013, 16, 77–81.
  • 41. Koestner A., Higgins R.: Tumors of the nervous system. W: Tumors in Domestic Animals, wyd. IV. 2002.
  • 42. Flatland B., Fry1 M., Newman S., Moore P., Smith J., Thomas W., Casimir R.: Large anaplastic spinal B-cell lymphoma in a cat. Vet Clin Pathol. 2008, 37, 389–396.
  • 43. Spodnick G.,Berg J., Moore F., Cotter S.: Spinal lymphoma in cats: 21 cases (1976–1989). J. Am. Vet. Med. Assoc. 1992, 200, 373–376.
  • 44. Fondevila D., Vilafranca M., Pumarola M.: Primary central nervous system T-cell lymphoma in a cat. Vet. Pathol.1998, 35, 550–553.
  • 45. Nakamoto Y., Ozawa T., Uchida K., Omori K., Hase K., Nakaichi M.: Primary intra-axial B-cell lymphoma in a cat.J. Vet. Med. Sci. 2009, 71, 207–210.
  • 46. Palus V., Volk H., Lamb C., Targett M., Cherubini G.: MRI features of CNS lymphoma in dogs and cats. Vet. Radiol.Ultrasound. 2012, 53, 44–49.
  • 47. Coupland S., Heimann H., Bechrakis N.: Primary intraocular lymphoma. A review of the clinical, histopathologicaland molecular biological features. Graefe’s ArchClin Exp Ophthalm. 2004, 240, 901–913.
  • 48. Geigy C., Dandrieux J., Miclard J., Kircher P., Howard J.: Extranodal B-cell lymphoma in the urinary bladder withcytological evidence of concurrent involvement of the gallbladder in a cat. J. Small Anim. Pract. 2010, 51, 280–287.
  • 49. Fontaine J., Heimann M., Day M.J.: Cutaneous epitheliotropic T-cell lymphoma in the cat: a review of the literatureand five new cases. Vet Derm. 2011, 22, 454–461.
  • 50. Swerdlow S., Berger F., Pileri S., Haris N., Jaffe E., Stein, H.: Lymphoplasmacytic lymphoma. pp. 194–195. W:WHO Classification of Tumours of Haematopoietic andLymphoid Tissues, IV ed. 2008.
  • 51. Andriko J., Swerdlow S., Aguilera N., Abbondanzo S.: Is lymphoplasmacytic lymphoma/immunocytoma a distinctentity? A clinicopathologic study of 20 cases. Am. J. Surg.Pathol. 2001, 25, 742–751.
  • 52. Kagawa Y., Yamashita T., Maetani S., Aoki Y., Sakaguchi K., Hirayama K., Umemura T., Taniyama H.: Cutaneouslymphoplasmacytic lymphoma with systemic metastasisin a cat. J. Vet. Med. Sci. 2011, 73, 1221–1224.
  • 53. Tsuboi M., Uchida K., Park E., Kotera Y., Seki T., Takahashi M., Nakayama H.: Systemic T cell large granular lymphocytelymphoma with multifocal white matter degenerationin the brain of a Japanese domestic cat. J. Vet. Med.Sci. 2010, 72, 795–799.
  • 54. Carter J., Tarigo J., Vernau W., Cecere T., Hovis R., Suter S.: Erythrophagocytic low-grade extranodal T-cell lymphomain a cat. Vet. Clin. Pathol. 2008, 37, 416–421.
  • 55. Hameed A., Truong L., Price V., Kruhenbuhl O., Tschopp J.: Immunohistochemical localization of granzyme B antigenin cytotoxic cells in human tissues. Am. J. Pathol.1991, 138, 1069–1075.
  • 56. Farcet J., Gaulard P., Marolleau J.: Hepatosplenic T-cell lymphoma: sinusal/sinusoidal localization of malignantcells expressing the T-cell receptor gamma delta. Blood.1990, 75, 2213–2219.
  • 57. Weidman E.: Hepatosplenic T cell lymphoma. A review on 45 cases since the first report describing the diseaseas a distinct lymphoma entity in 1990. Leukemia. 2000,14, 991–997.
  • 58. Fry M., Vernau W., Pesavento P., Bromel C., Moore P.: Hepatosplenic lymphoma in a dog. Vet. Pathol. 2003, 40,556–562.
  • 59. Fabrizio F., Calam A., Dobson J., Middleton S., Murphy S., Taylor S., Schwartz A., Stell A.: Feline mediastinallymphoma: a retrospective study of signalment, retroviralstatus, response to chemotherapy and prognostic indicators.J. Fel. Med. Surg. 2013.
  • 60. Geyer N., Reichle J., Valdes– Martinem A., Williams J., Goggin J., Leach L., Hanson J., Hill S., Axam T.: Radiographic appearance of confirmed pulmonary lymphoma in cats and dogs. Vet. Radiol. Ultrasound. 2010, 51,386–90.
  • 61. Smith K, O’Brien R.: Radiographic characterization of enlarged sternal lymph nodes in 71 dogs and 13 cats. J. Am.Anim. Hosp. Assoc. 2012, 48, 176–181.
  • 62. Stuetzer B., Simon K., Lutz H., Majzoub M., Hermanns W., Hirshberger J., Sauter-LouisC., Hartmann K.: Incidenceof persistent viraemia and latent feline leukaemia virusinfection in cats with lymphoma. J. Feline Med. Surg.2001, 13, 81–87.
  • 63. Weiss A., Klopfleisch R., Gruber A.: Prevalence of feline leukaemia provirus DNA in feline lymphomas. J. Feline Med. Surg. 2010, 12, 929–935.
  • 64. Schmiedt W., Grimes J., Holzman G., McAnulty J.: Incidence and risk factors for development of malignant neoplasia after feline renal transplantation and cyclosporine-based immunosuppression. Vet. Comp. Oncol. 2009, 7, 45–53.
  • 65. Durham A., Mariano A., Holmes E., Aronson L.: Characterization of post transplantation lymphoma in feline renaltransplant recipients. J. Comp. Path. 2013, 1–7.
  • 66. Gottschalk S, Rooney C., Heslop H.: Post-transplant lymphoproliferative disorders. Ann. Rev. Med. 2005, 56,29–44.
  • 67. Milman G., Smith K., Erles K.: Serological detection of Epstein-Barr virus infection in dogs and cats. Vet. Microbiol.2011, 150, 12–20.
  • 68. Huang S., Kozak P., Kim J., Habineza-Ndikuyeze G., Meade C.: Evidence of an oncogenic gammaherpesvirus indomestic dogs. Virology 2012, 427, 107–117.
  • 69. Taylor G., Blackburn D.: Infectious agents in human cancers: lessons in immunity and immunomodulation fromgammaherpesviruses EBV and KSHV. Canc. Letters. 2011,350, 263–278.
  • 70. Kano R., Sato E., Okamura T., Watanabe S., Hasegawa A.:. Expression of Bcl-2 in feline lymphoma cell lines.Vet. Clin. Pathol. 2008, 37, 57–60.
  • 71. Mabasa L., Cho K., Bae S., Walsh D., Asija P., Park C.: Lipotropes (methyl nutrients) inhibit growth of feline lymphomain vitro. Res. Vet. Sci. 2012, 93, 259–263.
Typ dokumentu
Bibliografia
Identyfikatory
Identyfikator YADDA
bwmeta1.element.agro-9ae746a8-7fe1-45ce-ba0f-a11572954685
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.